[{'address1': '9001 Spectrum Center Boulevard', 'city': 'San Diego', 'state': 'CA', 'zip': '92123', 'country': 'United States', 'phone': '858-836-5000', 'website': 'https://www.resmed.com', 'industry': 'Medical Instruments & Supplies', 'industryKey': 'medical-instruments-supplies', 'industryDisp': 'Medical Instruments & Supplies', 'sector': 'Healthcare', 'sectorKey': 'healthcare', 'sectorDisp': 'Healthcare', 'longBusinessSummary': "ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.", 'fullTimeEmployees': 9980, 'companyOfficers': [{'maxAge': 1, 'name': 'Mr. Michael J. Farrell BE, MBA, SM', 'age': 51, 'title': 'CEO & Chairman', 'yearBorn': 1972, 'fiscalYear': 2023, 'totalPay': 4226396, 'exercisedValue': 16501139, 'unexercisedValue': 47915704}, {'maxAge': 1, 'name': 'Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD', 'age': 81, 'title': 'Founder, Chair Emeritus & Director', 'yearBorn': 1942, 'fiscalYear': 2023, 'totalPay': 633825, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brett A. Sandercock', 'age': 56, 'title': 'Chief Financial Officer', 'yearBorn': 1967, 'fiscalYear': 2023, 'totalPay': 1340171, 'exercisedValue': 2632118, 'unexercisedValue': 3939752}, {'maxAge': 1, 'name': 'Mr. Robert A. Douglas', 'age': 63, 'title': 'Special Advisor', 'yearBorn': 1960, 'fiscalYear': 2023, 'totalPay': 2819941, 'exercisedValue': 13226082, 'unexercisedValue': 38689164}, {'maxAge': 1, 'name': 'Mr. Kaushik  Ghoshal', 'age': 54, 'title': 'Chief Commercial Officer - SaaS', 'yearBorn': 1969, 'fiscalYear': 2023, 'totalPay': 1634564, 'exercisedValue': 0, 'unexercisedValue': 4293348}, {'maxAge': 1, 'name': 'Mr. Alastair  Robertson', 'title': 'Chief Information Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Amy  Wakeham', 'title': 'Chief Investor Relations Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael J. Rider', 'age': 65, 'title': 'Chief Legal Officer', 'yearBorn': 1958, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jim  Ellis', 'title': 'Chief Compliance Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Yvonne-Katrin  Pucknat', 'title': 'Chief Marketing Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}], 'auditRisk': 1, 'boardRisk': 9, 'compensationRisk': 7, 'shareHolderRightsRisk': 3, 'overallRisk': 4, 'governanceEpochDate': 1725148800, 'compensationAsOfEpochDate': 1703980800, 'irWebsite': 'http://www.resmed.com/in/investors/investors.html?nc=investors', 'maxAge': 86400, 'priceHint': 2, 'previousClose': 37.62, 'open': 37.77, 'dayLow': 37.46, 'dayHigh': 37.88, 'regularMarketPreviousClose': 37.62, 'regularMarketOpen': 37.77, 'regularMarketDayLow': 37.46, 'regularMarketDayHigh': 37.88, 'dividendRate': 3.21, 'dividendYield': 0.0854, 'exDividendDate': 1723593600, 'payoutRatio': 0.2775, 'fiveYearAvgDividendYield': 0.79, 'beta': 0.691, 'trailingPE': 36.067307, 'forwardPE': 27.785183, 'volume': 740888, 'regularMarketVolume': 740888, 'averageVolume': 1888914, 'averageVolume10days': 1708540, 'averageDailyVolume10Day': 1708540, 'bid': 37.49, 'ask': 37.5, 'marketCap': 55649083392, 'fiftyTwoWeekLow': 21.14, 'fiftyTwoWeekHigh': 37.99, 'priceToSalesTrailing12Months': 11.877386, 'fiftyDayAverage': 32.7008, 'twoHundredDayAverage': 29.8349, 'trailingAnnualDividendRate': 1.92, 'trailingAnnualDividendYield': 0.051036682, 'currency': 'AUD', 'enterpriseValue': 6163160064, 'profitMargins': 0.21791, 'floatShares': 145617077, 'sharesOutstanding': 1469319936, 'heldPercentInstitutions': 0.11196999, 'impliedSharesOutstanding': 1483580032, 'bookValue': 33.111, 'priceToBook': 1.1328561, 'lastFiscalYearEnd': 1625011200, 'nextFiscalYearEnd': 1656547200, 'mostRecentQuarter': 1719705600, 'earningsQuarterlyGrowth': 0.272, 'netIncomeToCommon': 1020950976, 'trailingEps': 1.04, 'forwardEps': 1.35, 'pegRatio': 0.88, 'lastSplitFactor': '2:1', 'lastSplitDate': 1281571200, 'enterpriseToRevenue': 1.315, 'enterpriseToEbitda': 4.019, '52WeekChange': 0.6442307, 'SandP52WeekChange': 0.23285389, 'lastDividendValue': 0.53, 'lastDividendDate': 1723593600, 'exchange': 'ASX', 'quoteType': 'EQUITY', 'symbol': 'RMD.AX', 'underlyingSymbol': 'RMD.AX', 'shortName': 'RESMED CDI 10:1 [RMD]', 'longName': 'ResMed Inc.', 'firstTradeDateEpochUtc': 943484400, 'timeZoneFullName': 'Australia/Sydney', 'timeZoneShortName': 'AEST', 'uuid': 'c268f6fd-1530-3bbb-8a62-57d8ac8a2a14', 'messageBoardId': 'finmb_340196', 'gmtOffSetMilliseconds': 36000000, 'currentPrice': 37.51, 'targetHighPrice': 43.72, 'targetLowPrice': 30.39, 'targetMeanPrice': 35.09, 'targetMedianPrice': 34.7, 'recommendationMean': 2.1, 'recommendationKey': 'buy', 'numberOfAnalystOpinions': 12, 'totalCash': 238360992, 'totalCashPerShare': 1.622, 'ebitda': 1533543040, 'totalDebt': 873934976, 'quickRatio': 1.181, 'currentRatio': 2.589, 'totalRevenue': 4685297152, 'debtToEquity': 17.967, 'revenuePerShare': 7.967, 'returnOnAssets': 0.12699, 'returnOnEquity': 0.22703, 'freeCashflow': 1184884864, 'operatingCashflow': 1401260032, 'earningsGrowth': 0.269, 'revenueGrowth': 0.09, 'grossMargins': 0.57377, 'ebitdaMargins': 0.32731, 'operatingMargins': 0.31166, 'financialCurrency': 'USD', 'trailingPegRatio': 2.0999}]